Asbestos & Mesothelioma Studies

Autophagy Inhibitors Potentially Make Chemotherapy More Effective in Mesothelioma Patients

Autophagy is a natural and regulated self-degradative process in cells that plays a critical role in balancing sources of energy and removing aggravated proteins, damaged organelles, and pathogens. During autophagy, cells break down and recycle their different parts in order to make new cells. In mesothelioma, autophagy is necessary for[…]

Read More »

November is Lung Cancer Awareness Month

The National Cancer Institute places lung cancer as the leading cause of death from cancer in the United States. One out of every four cancer deaths is attributable to lung cancer, and in 2016 alone The America Cancer Society an estimated 158,080 people passed away from this disease. Lung cancer[…]

Read More »

Misconceptions about Mesothelioma

Mesothelioma is lung cancer One of the most common areas of the body where mesothelioma develops is the lung, and because of this, many misunderstand mesothelioma to be a type of lung cancer. In actuality, mesothelioma is cancer of the mesothelium – found in the lining of the heart, lungs,[…]

Read More »

Pleurectomy and Decortication Improve Survival, but May Impact Quality Of Life

Pleurectomy and Decortication (P/D) is a two-part surgical procedure that removes the pleural lining around the lungs (pleurectomy) and tumors along the surface area of the lung (decortication). To qualify for this surgery, mesothelioma patients must be in overall good health, and in the early stages of the disease. Since[…]

Read More »

The Effectiveness of Cisplatin and Pemetrexed in Pericardial Mesothelioma

Out of all the types of mesothelioma, pericardial mesothelioma is one of the rarest forms, accounting for only 0.002% of all known diagnosed mesothelioma cases. Mesothelioma is caused by asbestos exposure, and despite this knowledge and years of research, scientists and researchers still do not have a clear answer as[…]

Read More »

Opdivo, Yervoy, and Keytruda: Immunotherapy Options for Mesothelioma

Immunotherapy treatments are becoming known alternatives to chemotherapy in cancer patients who have had little success with traditional cancer treatments. With mesothelioma, often times first line treatments have little effect because the cancer is typically in the advanced stages by the time it is detected.  While there currently is no[…]

Read More »

Determining and Prolonging Survival Rates In Mesothelioma

The average survival rate for mesothelioma after diagnosis is less than one year; however, certain individuals will survive longer than others, but the reason as to why this is, is largely unknown.  The latest study to be published in Histopathology investigates what it is in the body that determines a[…]

Read More »

Skip to content